Agoracom Blog Home

Posts Tagged ‘stocks’

#CBD #Edibles Market to Exhibit an Astonishing CAGR of 24.30% – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 6:00 PM on Wednesday, April 8th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million In revenue and $CDN 2.48 million in EBITDA. FIND OUT MORE

CBD Edibles Market to Exhibit an Astonishing CAGR of 24.30%

  • Data Bridge Market Research analyses the market to account to USD 5160 million by 2027 growing at a CAGR of 24.30% in the forecast period
  • Rising global healthcare spending is expected to enhance the market growth

By Data Bridge Market Research

The CBD Edibles Market report comprehensively studies market definition, market segmentation, competitive analysis and key developments in the market. It comprises of fundamental, secondary and advanced information related to the global status and trend, market size, sales volume, market share, growth, future trends analysis, segment and forecasts from 2020 – 2027. It includes an extensive research on the current conditions of the industry, potential of the market in the present and the future prospects from various angles. Thus, the transparent, reliable and extensive market information of this CBD Edibles report will definitely develop business and improve return on investment (ROI).

Data Bridge Market Research analyses the market to account to USD 5160 million by 2027 growing at a CAGR of 24.30% in the forecast period. Rising global healthcare spending is expected to enhance the market growth.

An Overview of the Impact of COVID-19 on Particular Market:                   

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

CBD Edibles Market Overview 2020-2027: Some of the factors such as rising production of hemp, increasing awareness about the health advantages of cannabis, rising demand from the healthcare industry, and legalization of cannabis in the various industries is expected to enhance the CBD edibles market in the forecast period of 2020 to 2027. High cost of the CBD products and presence of stringent regulations is expected to hamper the market growth in the mentioned forecast period.

Global CBD Edibles Market Scope and Market Size

CBD edibles market is segmented of the basis of source type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

o Based on source type, the CBD edibles market is bifurcated into hemp and marijuana.

o The application segment of the CBD edibles market is segmented into personal care & cosmetics, pharmaceutical, food & beverage and others.

The Global CBD Edibles Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The market Report also calculate the market size, the report considers the revenue generated from the sales of This Report and technologies by various application segments. The data and the information regarding the CBD Edibles industry are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts.

Global CBD Edibles Industry 2020 Market Research Report is spread across 350 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Source: https://sciencein.me/2020/04/08/cbd-edibles-market-to-exhibit-an-astonishing-cagr-of-24-30-industry-size-share-demand-growth-segmentation-and-future-insights-2020-2027/

Mota Ventures $MOTA.ca Acquires Interest in Folium Life Sciences $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:25 AM on Wednesday, April 8th, 2020
Mota large
  • Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island.
  • Folium is nearing completion of the expansion of its existing cultivation facility, a further phase 2 expansion of the facility is expected.

VANCOUVER, BC / April 8, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTCPINK:PEMTF) (the “Company“) is pleased to announce that it has acquired (the “Acquisition“) all of the outstanding share capital of 1244780 B.C. Ltd. (the “Target“). The Acquisition was completed pursuant to a share exchange agreement (the “Purchase Agreement“), dated April 7, 2020, and entered into with an arms-length third-party (the “Vendor“). The sole asset of the Target consists of a 20% equity interest in Folium Life Sciences Inc. (“Folium“), which is in the process of developing a licensed indoor cannabis production facility located on Vancouver Island. In consideration for the Acquisition, the Company has issued 21,000,000 common shares.

Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island. Folium is nearing completion of the expansion of its existing cultivation facility. Its business plan calls for a further phase 2 expansion of the facility. Folium aims to produce a high quality and consistent cannabis product through its facilities.

“Canada has been a pioneer in legalization and early adoption of cannabis for both recreational and medical purposes. This equity position in a well-capitalized licensed producer provides Mota with a sound financial investment in the sector.” stated Ryan Hoggan, CEO of the Company.

Each of the Vendor, the Target, and Folium are at arms-length from the Company. The Acquisition does not constitute a fundamental change for the Company, nor has it resulted in a change of control of the Company within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Acquisition, the Company has issued 210,000 common shares (the “Administrative Fee Shares“) to a consultant who assisted with the Acquisition.

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Joel Shacker
President

For further information, readers are encouraged to contact Joel Shacker, President, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Cannabis Expo London 2020 – Experience the Europe Canna Expo SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 4:36 PM on Monday, April 6th, 2020

SPONSOR: Mota is seeking to become a vertically integrated global CBD brand. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota. Combined total sales of almost $29,000,000 with a EBITDA of approximately 12.5% (2019) . Click Here for More Info

Mota large

With the current climate of social distancing and uncertainty, it’s no surprise that events have been forced to cancel or postpone left, right, and centre. Despite the disruption caused by the Coronavirus pandemic, some organisers are persevering with their plans – at least for the time being. One of those events is the Europe Canna Expo, set to take place in  London in July.

The Europe Canna Expo (ECE) is scheduled to make a return to London for a 2-day event on 26-27 July. Following the success of last year’s Europe CBD expo at the same location, the ECE will aim to bring together over 90 speakers and 125 exhibitors.

The Venue

The ECE is set to make a return to the London ExCel Centre in Canning Town East London. The event was held at the venue in July 2019, with an array of exhibitors and speakers. This year, the Europe Canna Expo is expected to be even bigger. However, uncertainty remains over the event.

The ExCel Centre is currently home to the temporary Nightingale hospital – the improvised care centre for victims of the Coronavirus. It remains unclear when the need for the venue will be over as the UK’s Coronavirus lockdown continues.

Exhibitors and Speakers

However, should the expo go on as planned, attendees will be spoilt for choice with speakers and professionals set to provide insights into the CBD, cannabinoid, and medical cannabis industries. In addition, the event will be present a huge number of exhibitors including a variety of manufacturers and businesses.

Speakers will include international experts showcasing senior-level insights and global scientific research in the CBD, cannabinoid and medical cannabis sectors. Organisers of the event expect that attendees will include consumers and businesses, as well as policymakers and press.

The event will provide an opportunity for global leading brands to showcase their products to thousands of attendees. From CBD drinks and chocolates to medicinal products, the Europe Canna Expo plans to present the most innovative international brands.

Event Schedule

The ECE organisers are yet to release a detailed schedule for the two-day cannabis expo. This may be due to the ongoing uncertainty surrounding the Coronavirus lockdown. For more information and up-to-date announcements, visit the ECE London website.

https://canex.co.uk/cannabis-expo-2020-europe-canna-expo-london/

Using #Telehealth in a #Pandemic #Covid19: Focus on Flexibility, Scalability – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 9:40 AM on Monday, April 6th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Using Telehealth in a Pandemic: Focus on Flexibility, Scalability

Executives from three different health systems talk about how they’ve used telehealth to meet the demands created by the Coronavirus pandemic – and how those services are laying the groundwork for ‘the new normal.’

By Eric Wicklund

  • Healthcare providers are scrambling to keep up with the demand for telehealth services as the Coronavirus pandemic sweeps across the nation
  • Many are seeing unexpected benefits in the shift to connected health – and hoping the momentum continues after the emergency is over

‘Take Care of the Patients First’

“There’s been a lot of spontaneous action,” says Alexa Boer Kimball, CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, a network of roughly 2,900 physicians spread across eastern Massachusetts.

“The key is to take care of the patients first,” she says.

Kimball remembers using telemedicine as far back as 1998, though more recently the network had focused on urgent on-demand care. Now her physicians are seeing thousands more patients each week via telehealth than they had seen just a few weeks ago.

While the traditional barriers – reimbursement, patient and provider buy-in, technology – “have always been there,” Kimball says the accelerated pace of the nation’s response to the emergency has allowed providers to jump in and try things out.

“The first thing we realized was that you can do a lot of things just on the phone,” she says.

Actions by state and federal officials have loosened a lot of those barriers, allowing providers to test new platforms and see more reimbursement. Kimball says her providers have long clashed with payers over coverage, and she’s hoping the success they’re seeing now will convince payers to maintain these new guidelines after the pandemic has eased.

“Right now we’re pretty confident we’ll be reimbursed for that business, but we’re still not sure,” she says. “This (rapid uptake) is kind of proof in the pudding. We need to make sure we have the data to prove our point.”

Kimball advises providers to “pay attention to all the guidance” right now, identifying both state and federal guidelines that have a direct effect and positioning telehealth and mHealth services to take advantage of those new rules. This includes developing a compliance and payer-specific billing plan, and massaging that plan to cover not just Coronavirus cases, but all cases.

“We need to be ready for a new (environment),” she says. “There’s no going back.”

‘We … Jumped Forward 10 Years on the Adoption Curve’

Out in Renton, WA, the Providence St. Joseph Health system was caught in the middle of the first wave of Coronavirus cases. But Aaron Martin, Executive Vice President and Chief Digital Officer for the six-state, 51-hospital health system, says leadership had recognized the value of virtual care six years ago and had the infrastructure in place to tackle the surge.

Still, he says, they were caught by surprise by a tenfold increase in telehealth visits and a sevenfold jump in care providers joining the platform.

“We had to move very quickly from feature-driven (virtual health offerings) to scale-driven,” he says. “We basically jumped forward 10 years on the adoption curve.”

Martin says PSJ has a large digital health innovation program, employing some 120 software engineers and producing more than a few tools and incubator spin-outs, like Xealth. The health system also partners with telehealth and mHealth companies to test out the latest in tools and services.

That helped the health system expand from its fast-growing ExpressCare Virtual telehealth platform to a stable of services that now includes remote patient monitoring for roughly 300 patients in the Seattle area. That program will soon be expanded throughout the enterprise to help other hospitals manage their populations at home. 

Martin says the health system realized very quickly that it had to have a plan in place for expanding and evolving its virtual care services. 

“Move fast, but make sure you’re being very, very diligent about things,” he says. “Understand all the processes in place, and make sure the technology is very fungible and easy to configure.” 

In addition, make sure all telehealth and mHealth services are tested and fine-tuned not only by IT, but by the clinicians who will use them. 

“And be prepared to learn,” he adds. “We will learn some things that work in virtual visits, and we will learn some things that absolutely don’t work.” 

That includes addressing three specific goals: Make sure all online content is from a trusted source, be prepared to adopt all-digital transactions, and focus on engagement, both to get patients through the digital door and to keep them there for future care. 

With regard to future care, Martin says “we’re already thinking of the new normal.” That means preparing to transition from Coronavirus triage and care to a platform that can take on elective procedures, chronic care management and specialty care. 

Martin expects the healthcare industry, pushed by consumer demand and the successes of using technology during the pandemic, to pressure state and federal regulators to keep guidelines in place that expand telehealth coverage and reimbursement. But he also expects the industry will see an increase in fraud and abuse, as some look to take advantage of that new normal. 

“There’s going to be some time to adjust,” he says. “Let’s just make sure we don’t back ourselves into a corner (with new legislation) that we can’t get out of.” 

‘We Know It’s a Marathon’ 

At Houston Methodist, the health system has weathered the likes of Hurricanes Allison and Harvey, not to mention the surge of people displaced by Hurricane Katrina. Stephen Spielman, Senior Vice President of the Houston Methodist Physician Organization and President of the Methodist Primary Care Group, says the seven-hospital system has learned a lot from past disasters. 

“We’ve been through this – we know how this feels,” he says. “We know it’s a marathon.” 

Spielman says the health system has been expanding its platform since partnering with American Well some three years ago on its first virtual care service, and now has a broad network of services. 

The Coronavirus pandemic, however, pushed the health system into uncharted territory. 

He says Houston Methodist’s Virtual Urgent Care service worked well in the direct-to-consumer arena – handling the increase from 30-40 visits a day to 250-300 visits – but it didn’t mesh well with the network’s Epic electronic health record, giving providers fits as they tried to conduct telehealth visits with established patients. So the health system created a second telehealth network on the Epic MyChart platform, allowing providers to integrate primary and specialty care visits with each patient’s EMR. 

“This gave us better flexibility, and our physicians loved it,” Spielman says, adding that the shift to a virtual platform took only 10 days. It’s also giving network executives the confidence to push ahead with their third connected health platform: E-visits. 

Along the way, Spielman says he’s learned some interesting lessons. 

While federal authorities loosened the guidelines for video visits through consumer-friendly platforms like Skype and FaceTime, “it’s been a little bit cumbersome to do that operationally,” he says. Those tools might be great for quick, one-off visits demanded by the epidemic, but they don’t integrate will with the health system’s telemedicine infrastructure – and likely won’t be an option when the emergency passes and some of the old rules and regulations come back into play. 

On the other hand, Spielman says he’s had great success with the Press Gainey patient surveys sent out after every telehealth encounter, giving health system executives a good idea of what patients like and don’t like about virtual care. With so many people quarantined at home, more patients have time on their hand to complete those surveys. 

At present, Spielman says Houston Methodist is ramping up its telehealth platforms to not only deal with an expected surge in Coronavirus cases, but to give patients with other needs – treatment for issues not related to the pandemic – the same access to virtual care as those with the virus. The health system is also looking to expand its telemental health offerings to help staff dealing with the stress of the pandemic. 

Looking ahead, he says the health network will look to keep the momentum going after the emergency by expanding its telehealth services for chronic care management, health and wellness and other ancillary services that have been pushed to the side to tackle the virus. 

“What we’re learning here will change healthcare permanently,” he says. “The genie is out of the bottle. Telehealth is our passion now.”

Source: https://mhealthintelligence.com/news/using-telehealth-in-a-pandemic-focus-on-flexibility-scalability

INTERVIEW: Empower $CBDT.ca #CBD Clinics Visits Climb By 478% In Q1 As #Coronavirus Stress Drives Demand For CBD $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:41 PM on Sunday, April 5th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 800% in February. 590% in March and 480% for Q1.  But will Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower has had to actually increase operating hours due to demand from existing patients who need their CBD medication more than ever, as well as, new patients who are experiencing anxiety and stress through the COVID-19 pandemic.  

Moreover, the Company has also  entered expanded into telemedicine across multiple states for patients who can’t get to a clinic but need a consultation with doctors over the phone to determine the best CBD medications for home delivery.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment

Primo Nutraceuticals Inc., $PRMO.ca Signs Share Acquisition LOI with Celebrity brand Beauty Kitchen $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 3:03 PM on Friday, April 3rd, 2020
  • Company has signed a non-binding letter of intent with Heather Marianna, LLC, doing business as Beauty Kitchen
  • The LOI is non-binding and subject to possible change and the signing of a definitive agreement

VANCOUVER, British Columbia, April 03, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”)Pursuant to discussions with IIROC (Investment Industry Regulatory Organization of Canada) Primo’s board and management team are providing more clarity to its shareholders in regards to the press release issued on March 31st, 2020.

The Company has signed a non-binding letter of intent (LOI) with Heather Marianna, LLC, doing business as Beauty Kitchen, a Nevada company, (“Beauty Kitchen”).  The LOI is non-binding and subject to possible change and the signing of a definitive agreement.

Primo and Beauty Kitchen intend to draft and execute a definitive agreement (the “Definitive Agreement”) with detailed terms and conditions in the near future.  Beauty Kitchen intends to incorporate a Canadian corporation, Marianna, Inc., (“Marianna, Inc.”) in which it will conduct operations in Canada. Primo will acquire an ownership interest of 25% of the common voting (TBC) shares in Marianna, Inc., for consideration to be determined in the Definitive Agreement. Primo wishes to inform its shareholders that the transaction described by the LOI is subject to change pending signing of the Definitive Agreement.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.beautykitchenonline.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.

CLIENT FEATURE: Mota Ventures $MOTA.ca Continues to Define the European CBD Market $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 1:27 PM on Friday, April 3rd, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

RECENT HIGHLIGHTS

  • Immune Support Product Line Launched on March 14, 2020 Acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems, yielding an average initial order value of $189.00 USD.
  • First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
  • Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
  • February 2020 revenue represents an increase of 832% over the same period last year.
  • Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.

Formalized Joint Venture With Bevcanna Enterprises: Read More

Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations

Company will provide manufacturing, marketing and distribution infrastructure in the European market.

Parties have determined an initial product launch and will provide further details on specific regions and timing once finalized

Formalized Collaboration for Sativida US Expansion Read More 

Acquired the intellectual property and trade names of Sativida

Unified Funding will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing

Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico

Entered into Licensing Agreement with Phenome One Read More

A privately held full-service live genetic and seed preservation cannabis company.

Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars

Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars

2 World Class Brands:

#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS

HIGHLIGHTS:

  • Leader in online CBD sales in North America
  • Crop to package model: US grown CBD hemp
  • Acquired at a 1.5 times revenue valuation
  • Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
  • 2019 Sales of $19.2M USD/ EBITDA of 2.7M USD

  #2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS

HIGHLIGHTS:

  • Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
  • Number one search-ranked online retailer in Spain and Mexico
  • Award winning product line known for its minimal heavy metal content and accurate CBD levels
  • 100% organic products

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Mota has established distribution networks through the acquisition of First Class CBD in the United States and Sativida in Europe. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

Hub on Agoracom

FULL DISCLOSURE: Mota Ventures. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Putting Your Heartbeat Into The Cloud For Instant Diagnostics $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:40 PM on Friday, April 3rd, 2020

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

CardioComm Solutions Partners with CareOS to Bring Consumer ECG Monitoring into the Connected Home

  • Entered into a partnership agreement with CareOS SAS (France), a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub
  • The partnership will see CardioComm’s FDA and Health Canada cleared GEMS™ ECG management software and Smart Monitoring ECG reading service integrated into the touch and gesture controlled smart mirror
  • GEMSTM software will be capable of recognizing ECG devices made by multiple device manufacturers which will permit CareOS customers more options in choosing a device of their preference.

Industry News

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

Have the next crop of #battery metals producers been oversold? – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 1:27 PM on Thursday, April 2nd, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Have the next crop of battery metals producers been oversold?

  • Could a large global recession as a result of the COVID-19 crisis alter the consensus long term outlook for battery raw materials like lithium, cobalt, graphite, nickel and copper?
  • No, says CRU Group senior analyst George Heppel. Irrespective of temporary recessions or market downturns, electrification of the global automotive sector remains “inevitable” in the long run.

By: Reuben Adams

Right now, COVID-19 is freezing the embryonic battery supply chain. But for the next crop of battery metals producers — impacted by the broader share market rout — ‘deals and discussions’ are very much continuing behind the scenes.

The short-term outlook for the lithium-ion supply chain, like everything else, is uncertain. Could a large global recession as a result of the COVID-19 crisis alter the consensus long term outlook for battery raw materials like lithium, cobalt, graphite, nickel and copper?

No, says CRU Group senior analyst George Heppel. Irrespective of temporary recessions or market downturns, electrification of the global automotive sector remains “inevitable” in the long run.

“Investment in e-mobility reduces CO2 emissions, improves air quality and will eventually make a huge amount of financial sense to the average consumer as battery costs decline and manufacturing scale ramps up,” he says.

The future remains bright for high quality battery facing stocks, especially those placed to take advantage of the next upsurge in demand in 2022/2023.

In the short-term, Heppel says the automotive sector – and EVs by extension – are experiencing a reduction in demand due to quarantine.

“Many consumers in key markets can’t leave their house for non-essential reasons right now, let alone buy cars,” he says.

“We have heard reports that 85 per cent of automotive manufacturing capacity in Germany is currently idle as a result of the pandemic.

“However, in theory this should create ‘pent up demand’ which is released when quarantines are relaxed.”

Ongoing economic uncertainty will also hinder attempts to push new battery metals projects into production in the short-term, Benchmark Mineral Intelligence analyst Andrew Miller says.

“As a result, the potential for a supply crunch over the coming years will increase – money needs to go into new expansions today to fuel the growth in EV production in 2022/23 onwards,” he says.

Battery focused nickel sulphide play Blackstone Minerals (ASX:BSX) agrees that supply will tighten due to the reduced funding into new projects going forward “which will reduce the supply of nickel (particularly from laterites) and only increase the gap between supply and demand”.

“Tread carefully, but I believe now is the time to be buying those mining stocks you’ve been watching for months,” Blackstone managing director Scott Williamson told Stockhead.

“I can’t see the junior battery metals miners getting any cheaper than they are today.”

EV ‘engine room’ China is rebounding already

As the “backbone of the EV market to date”, China’s apparent early economic recovery from COVID-19 will help support the battery supply chain, Miller says.

“What was meant to be the year battery demand diversified outside China may now see China play a more important role than ever before,” he says.

“There are also expectations that EVs will be included in the country’s stimulus efforts which could bolster the long-term outlook.”

China moving to insulate domestic #EV market as the country’s supply chain ramps back up following Q1 slowdown. More of these types of policies likely to follow over coming months: https://t.co/XUea3iteT5

— Andrew Miller (@amiller_bmi) March 31, 2020

Advanced explorer AVZ Minerals (ASX:AVZ) is driving the mammoth Manono project in the DRC toward a development decision.

As part of that process, it is aiming to lock in a lithium offtake and strategic investment deal with Chinese firm Yibin Tianyi.

Yibin Tianyi is set to become a key cog in the supply chain of Contemporary Amperex Technology (CATL), the world’s biggest lithium-ion battery maker.

In late March,  Yibin Tianyi signed a new five-year, 75,000-tonne-per-annum (tpa) offtake agreement with WA producer Pilbara Minerals (ASX:PLS).

AVZ managing director Nigel Ferguson told Stockhead the company had seen “increased and faster responses” out of the companies they were talking to in China over the last few weeks.

“They appear to be re-awakening after the significant lock downs there,” he says.

“OEM/car manufacturers are committed to their EV plans, and while the current events are certainly causing disruptions, I have not heard of any OEM changing its long-term EV growth plans.

“For AVZ, with our significant long-life, high-quality resource underpinned by the EV thematic, the future is very bright. Current share price values certainly do not represent that.”

Source: https://stockhead.com.au/resources/have-the-next-crop-of-battery-metals-producers-been-oversold/

#Mhealth Project to Crowdsource Consumer Data for #Coronavirus Research – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:49 AM on Wednesday, April 1st, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

mHealth Project to Crowdsource Consumer Data for Coronavirus Research

  • UCSF researchers are deploying an mHealth app to gather information on daily health habits
  • They’re hoping to gain insight on how behaviors might affect the course of the virus or outcomes in those who are infected

By Eric Wicklund

March 31, 2020 – mHealth researchers are using smartphones to crowdsource Coronavirus research.

The University of California at San Francisco has launched COVID-19 Citizen Science (CCS), a project aimed at gathering insights from people around the world on the virus. Participants are being asked to download an mHealth app, complete a survey about their daily health habits, complete a weekly follow-up survey and pass it on to friends.

“We are asking each participant to share the link to recruit at least five others,” Gregory Marcus, MD, MAS, a professor at UCSF’s Department of Medicine and the project’s co-leader, said in a press release. “We want to demonstrate that the number of people signing up for this scientific study and contributing their data can increase exponentially, faster than the disease itself.”

Participants will also be able to provide continuous GPS data and information from mHealth wearables, such as Fitbit activity bands and smartwatches.

(For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.)

The program is one of several aimed at using connected health platforms to study the pandemic. Just down the highway in San Diego, the Scripps Research Translational Institute has launched a project aimed at measuring the value of mHealth wearables in detecting emerging viral outbreaks.

Another project launched out of UCSF, meanwhile, is using mHealth wearables to monitor frontline care workers who’ve been exposed to the virus.

Marcos is no stranger to telehealth projects. In 2013 he helped to launch the Health eHeart Study, which used online and mHealth tools to collect and analyze heart health data. That, in turn, led to the launch of a study in 2018 that combined mHealth wearables with AI to determine whether a cardiac monitoring platform could help detect early signs of diabetes.

Marcos says CCS aims to identify behaviors, influences and factors that might affect the course of the virus and outcomes after infection, and he feels the study could be the largest-ever prospective epidemiological study of infectious diseases.

“Social distancing keeps many protected,” he said, “but joining together to contribute data will help us beat this thing.”

Source: https://mhealthintelligence.com/news/mhealth-project-to-crowdsource-consumer-data-for-coronavirus-research